Cabaletta Bio (CABA) Fundamental Analysis: Revenue, Earnings & Valuation

5.26 / 10

Netural

Fundamental score sits at 5.26. Asset‑MV and Profit‑MV are strong contributors, while Revenue‑MV and Gross margin lag. Inventory turnover is solid, but cash position is modest and income‑tax ratio is weak. Overall, fundamentals are moderate with notable strengths and weaknesses.

Analysis Checks(7/10)

Revenue-MV

Value-0.28

Score1/3

Weight11.02%

1M Return5.44%

Inventory turnover ratio

Value47.57

Score3/3

Weight13.38%

1M Return6.65%

Gross profit margin (%)

Value36.91

Score1/3

Weight0.52%

1M Return0.36%

Profit-MV

Value0.41

Score2/3

Weight12.58%

1M Return6.36%

Income tax / Total profit (%)

Value-5.52

Score1/3

Weight0.31%

1M Return0.21%

Current assets turnover ratio

Value1.78

Score2/3

Weight2.89%

1M Return1.91%

Fixed assets turnover ratio

Value7899.90

Score3/3

Weight2.67%

1M Return1.76%

Cost of sales ratio (%)

Value70.30

Score3/3

Weight6.65%

1M Return4.08%

Asset-MV

Value-0.48

Score3/3

Weight37.65%

1M Return15.70%

Cash-MV

Value-0.09

Score2/3

Weight12.33%

1M Return6.19%

Is CABA undervalued or overvalued?

CABA scores 5.26/10 on fundamentals and holds a Fair valuation at present. Backed by its -126.98% ROE, 0.00% net margin, -1.78 P/E ratio, 2.66 P/B ratio, and 10.26% earnings growth, these metrics solidify its Netural investment rating.